Creutzfeldt-Jakob disease in a young woman

Lancet

Volumn 347, Issue 9006, 1996, Pages 945-948

  Tabrizi, S J ^a   Howard, R S ^a,d,e   Collinge, J ^b,c   Rossor, M N ^c,d   Scaravilli, F ^d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; FEMALE; HUMAN; NEUROPATHOLOGY; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0042613323     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91419-1     Document Type: Article

References (24)

1. Collinge J, Owen F, Poulter M, et al. Prion dementia without characteristic pathology. Lancet 1990; 336: 7-9.
2. Horopian DS, Powers JM, Schaumburg HH. Kuru-like neuropathological changes in a North American. Arch Neurol 1972; 27: 555-61.
3. Roos R, Gajdusek DC, Gibbs CJ Jr. The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 1973; 96: 1-20.
4. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979 I Clinical features. J Neurol Neurosurg Psychiatry 1984; 47: 134-410.
5. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
6. Brown P, Rodgers-Johnson P, Cathala F, Gibbs CJ Jr, Gajdusek DC. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility and differential diagnosis. Ann Neurol 1984; 16: 295-304.
7. Goldfarb LG, Brown P. The transmissible encephalopathies. Ann Rev Med 1995; 46: 57-65.
8. Prusiner SB, DeArmond SJ. Prion diseases and neurodegeneration. Ann Rev Neurosci 1994; 17: 311-39.
9. Collinge J, Palmer MS. Molecular genetics of human prion diseases. Phil Trans R Soc Lond B 1994; 343: 371-78.
10. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987; 37: 895-904.
11. Owen F, Poulter M, Collinge J, Crow TJ, Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet 1990; 46: 1215-16.
12. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-42.
13. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-42.
14. Brown P, Cervenakova L, Goldfarb MD, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994; 44: 291-93.
15. Pruisner SB, Scott M, Foster D, et al. Transgenic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63: 673-86.
16. Collinge J, Brown J, Hardy J, et al. Inherited prion disease with 144 base pair gene insertion: II: clinical and pathological features. Brain 1992; 115: 687-710.
17. Palmer MS, Collinge J. Mutations and polymorphisms in the prion protein gene. Human Mutation 1993; 2: 168-73.
18. Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet 1995; 346: 1155-56.
19. Britton TC, Al-Sarraj S, Shaw C, Campbell T, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995; 346: 1155.
20. Pattison IH. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Gajdusek CJ, Gibbs CJ, Alpers MP, eds. Slow, latent and temperate virus infections, NINDB Monograph 2, Washington DC: US Government Printing, 1965: 249-57.
21. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond [B Biol Sci] 1994; 343: 405-11.
22. Collinge J, Palmer MS, Sidle KCL, et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 1995; 378: 779-83.
23. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expresing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79-90.
24. Rossor MN. Catastrophe, chaos and Alzheimer's disease. J R Coll Physicians Lond 1995; 29: 412-18.